CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1

NCT02504008 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Complex Regional Pain Syndrome
Reflex Sympathetic Dystrophy

Interventions

DRUG: AXS-02 (oral zoledronate)
DRUG: Placebo

Sponsor

Axsome Therapeutics, Inc.